|4Mar 31, 3:05 PM ET

ARCA biopharma, Inc. 4

4 · ARCA biopharma, Inc. · Filed Mar 31, 2010

Insider Transaction Report

Form 4
Period: 2010-03-29
Transactions
  • Sale

    Common Stock

    2010-03-29$7.56/sh140,000$1,058,4001,337,612 total
Footnotes (1)
  • [F1]Represents 1,262,163 shares of Common Stock and 75,449 warrants to purchase shares of Common Stock held by Atlas Venture Fund VII, L.P. These shares are held directly by AV VII. Atlas Venture Associates VII, L.P., or AVA VII LP, is the sole general partner of AV VII. Each of Atlas VII and AVA VII LP disclaims beneficial ownership of such shares except to the extent of it's pecuniary interest therein.

Documents

1 file
  • 4
    a4.xmlPrimary

    4